SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,788,471 | -51.3% | 17,986,781 | +5.5% | 0.07% | -49.3% |
| Q2 2023 | $22,168,172 | -7.7% | 17,052,440 | +25.0% | 0.13% | -10.1% |
| Q1 2023 | $24,010,654 | -39.6% | 13,642,417 | +7.8% | 0.15% | -44.2% |
| Q4 2022 | $39,723,368 | -38.2% | 12,650,754 | -3.6% | 0.27% | -40.3% |
| Q3 2022 | $64,298,000 | +25.3% | 13,122,116 | +5.9% | 0.45% | +38.0% |
| Q2 2022 | $51,304,000 | -16.5% | 12,392,319 | +17.2% | 0.32% | +6.9% |
| Q1 2022 | $61,452,000 | -25.2% | 10,576,997 | -3.5% | 0.30% | -9.6% |
| Q4 2021 | $82,207,000 | -14.4% | 10,960,982 | +2.9% | 0.34% | -14.1% |
| Q3 2021 | $96,011,000 | -22.2% | 10,656,042 | +3.4% | 0.39% | -22.2% |
| Q2 2021 | $123,342,000 | -4.7% | 10,304,295 | -0.2% | 0.50% | -13.8% |
| Q1 2021 | $129,415,000 | -17.7% | 10,328,423 | +2.5% | 0.58% | -24.9% |
| Q4 2020 | $157,180,000 | +134.0% | 10,072,381 | +41.7% | 0.77% | +81.3% |
| Q3 2020 | $67,179,000 | +11.0% | 7,108,935 | +5.3% | 0.43% | -2.5% |
| Q2 2020 | $60,508,000 | +60.0% | 6,753,143 | +13.7% | 0.44% | +11.2% |
| Q1 2020 | $37,828,000 | -39.6% | 5,938,434 | -20.7% | 0.39% | -23.3% |
| Q4 2019 | $62,666,000 | +0.4% | 7,487,017 | +8.5% | 0.51% | -13.6% |
| Q3 2019 | $62,432,000 | -12.2% | 6,898,523 | +4.5% | 0.60% | -14.0% |
| Q2 2019 | $71,070,000 | +15.7% | 6,598,908 | +2.5% | 0.69% | +3.4% |
| Q1 2019 | $61,418,000 | +5.3% | 6,437,908 | +26.8% | 0.67% | -13.9% |
| Q4 2018 | $58,304,000 | -24.3% | 5,078,738 | +11.8% | 0.78% | -11.7% |
| Q3 2018 | $77,031,000 | +33.7% | 4,544,596 | +12.0% | 0.88% | +26.8% |
| Q2 2018 | $57,626,000 | -17.9% | 4,058,167 | +9.9% | 0.69% | -23.5% |
| Q1 2018 | $70,167,000 | -8.9% | 3,692,981 | -21.4% | 0.91% | -11.3% |
| Q4 2017 | $77,056,000 | -1.0% | 4,698,511 | -9.5% | 1.02% | -3.3% |
| Q3 2017 | $77,862,000 | +27.7% | 5,190,789 | -25.1% | 1.06% | +24.4% |
| Q2 2017 | $60,989,000 | +66.1% | 6,930,535 | -1.8% | 0.85% | +57.1% |
| Q1 2017 | $36,713,000 | +65.9% | 7,060,135 | -2.7% | 0.54% | +62.0% |
| Q4 2016 | $22,132,000 | -31.5% | 7,256,260 | +3.9% | 0.33% | -30.6% |
| Q3 2016 | $32,325,000 | -19.7% | 6,981,681 | +0.4% | 0.48% | -21.9% |
| Q2 2016 | $40,268,000 | +0.9% | 6,954,761 | +0.0% | 0.62% | +1.0% |
| Q1 2016 | $39,915,000 | -35.5% | 6,953,753 | +2.6% | 0.61% | -28.5% |
| Q4 2015 | $61,905,000 | +60.9% | 6,780,390 | -0.6% | 0.85% | +66.0% |
| Q3 2015 | $38,483,000 | +12.3% | 6,823,230 | +120.7% | 0.51% | +37.4% |
| Q2 2015 | $34,283,000 | -28.6% | 3,091,386 | +1.0% | 0.37% | -24.9% |
| Q1 2015 | $47,990,000 | +6.2% | 3,060,587 | +3.0% | 0.50% | +6.2% |
| Q4 2014 | $45,205,000 | +41.1% | 2,972,059 | +0.0% | 0.47% | +39.6% |
| Q3 2014 | $32,040,000 | -29.1% | 2,970,812 | +0.4% | 0.34% | -23.5% |
| Q2 2014 | $45,168,000 | -20.1% | 2,957,946 | -5.4% | 0.44% | -19.9% |
| Q1 2014 | $56,503,000 | +26.6% | 3,125,160 | -2.8% | 0.55% | +25.1% |
| Q4 2013 | $44,646,000 | +40.3% | 3,214,232 | +5.8% | 0.44% | +32.7% |
| Q3 2013 | $31,828,000 | +31.1% | 3,037,058 | -2.3% | 0.33% | +24.1% |
| Q2 2013 | $24,277,000 | – | 3,108,482 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |